Chemogenomics combines target and drug discovery by employing active compounds, which function as ligands, as probes to help characterize proteome functions. Chemogenomics is the actual systematic screening of targeted chemical library of small molecules against individual medication target families (e.g, GPCRs, nuclear receptors, kinases, proteases, and others) with the best goal of identification of novel medications and drug finds.